Cerbios | chemanager-online.com - Chemistry and Life Science

Sep. 11, 2019
Topics
The Pharma CDMO Challenge
The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manufacturing to contract development and manufacturing ...
Jan. 24, 2019
News & Opinions
Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units
Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units. ...
Jan. 24, 2019
News & Opinions
Cerbios Expands HPAI Manufacturing Capacity
Lugano, Switzerland-based chemical and biological API manufacturer Cerbios announced that its board of directors has approved the installation of a new production line in its building dedicated for high potency active ingredients (HPAIs). ...
Oct. 03, 2018
Topics
M&A in Pharma and CRO/CMO Industry
Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself. The recent acquisitions of Capsugel by Lonza and of ...
Oct. 02, 2017
Topics
Confidentiality is a Potential Pitfall
Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. What do the outsourcing partners have to do in order to maintain their focus and guarantee confidentiality in ...
Oct. 02, 2017
Topics
Earning a Large Chunk of the Cake
Daniel Mueller: The most obvious effect of consolidation in the pharmaceutical industry is a pronounced shift to those activities within the organization that provide the most profitable returns, closely followed by outsourcing activities ...
Oct. 02, 2017
Topics
A Partner to Relieve the Strain
Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will it even intensify? ...
Oct. 02, 2017
Topics
M&A in Pharma and CRO/CMO Industry
Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your outsourcing partners or customers. Distractions or ...
Oct. 13, 2016
News & Opinions
Cerbios joins CMC Biologics and IDT Biologika in ADC Collaboration
CMC Biologics and IDT Biologika announced the addition of Cerbios and Oncotec Pharma to PROVEO, their strategic collaboration for providing a complete and efficient solution to the market for the process development and manufacture of ...
Sep. 21, 2016
Topics
Cerbios' new State-of the-art R&D Centre for HPAI and mAb Development
On February 15th, 2016, Cerbios Pharma officially opened its new R&D Centre in Lugano, Switzerland. During the past 15 years, Cerbios has heavily invested in infrastructures, in acquisitions and company participations driven by ...

12 3

Register now!

The latest information directly via newsletter.

GIT Verlag